RxDoctor Payments Data

Sara Moncrief, MD

Surgery · Rochester, MNNPI 1669762209

Payments from drug & device makers

$2,372in general payments, 2019–2025

Across 65 payments — averaging $36.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • KCI USA, Inc.$465
  • Kerecis Limited$222
  • Lifenet Health$56
  • Hydrofera LLC$38
  • Melinta Therapeutics, LLC$35
  • plus $67 from 3 others

What the payments were for

  • Speaking & faculty fees$1546%
  • Travel & lodging$24310%
  • Food & beverage$1,97583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.50$1,489
KCI USA, Inc.2$465
Kerecis Limited3$222
Lifenet Health4$56
Hydrofera LLC2$38
Melinta Therapeutics, LLC1$35
Solventum Corporation1$30
Bioventus LLC1$23
TEI Medical Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,372 in reported general payments places this provider in the 55th percentile of 498 surgery providers in Minnesota.

See all surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$60,408
Medicare patients
98
Services billed
1,115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$358
Fluconazole11$113
Ciprofloxacin Hcl17$112

Paid to pharmacies, not to this prescriber.

Other surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →